The human ankyrin-1 gene is selectively transcribed in erythroid cell lines despite the presence of a housekeeping-like promoter.

To begin to study the sequence variations identified in the 5' flanking genomic DNA of the ankyrin gene in ankyrin-deficient hereditary spherocytosis patients and to provide additional insight into our understanding of the regulation of genes encoding erythrocyte membrane proteins, we have identified and characterized the erythroid promoter of the human ankyrin-1 gene. This compact promoter has characteristics of a housekeeping gene promoter, including very high G+C content and enzyme restriction sites characteristic of an HTF-island, no TATA, InR, or CCAAT consensus sequences, and multiple transcription initiation sites. In vitro DNAseI footprinting analyses revealed binding sites for GATA-1, CACCC-binding, and CGCCC-binding proteins. Transfection of ankyrin promoter/reporter plasmids into tissue culture cell lines yielded expression in erythroid, but not muscle, neural, or HeLa cells. Electrophoretic mobility shift assays, including competition and antibody supershift experiments, demonstrated binding of GATA-1, BKLF, and Sp1 to core ankyrin promoter sequences. In transfection assays, mutation of the Sp1 site had no effect on reporter gene expression, mutation of the CACCC site decreased expression by half, and mutation of the GATA-1 site completely abolished activity. The ankyrin gene erythroid promoter was transactivated in heterologous cells by forced expression of GATA-1 and to a lesser degree BKLF.

[1]  D. Bodine,et al.  A Human β-Spectrin Gene Promoter Directs High Level Expression in Erythroid but Not Muscle or Neural Cells* , 1999, The Journal of Biological Chemistry.

[2]  W T Tse,et al.  Red blood cell membrane disorders , 1999, British journal of haematology.

[3]  B. Forget,et al.  Hematologically important mutations: spectrin and ankyrin variants in hereditary spherocytosis. , 1998, Blood cells, molecules & diseases.

[4]  J. J. Sharp,et al.  An alternative first exon in the distal end of the erythroid ankyrin gene leads to production of a small isoform containing an NH2-terminal membrane anchor. , 1998, Genomics.

[5]  J. Bieker.  Erythroid‐specific transcription , 1998, Current opinion in hematology.

[6]  B. Forget,et al.  An Alternate Promoter Directs Expression of a Truncated, Muscle-specific Isoform of the Human Ankyrin 1 Gene* , 1998, The Journal of Biological Chemistry.

[7]  B. Forget,et al.  Structure and Organization of the Human Ankyrin-1 Gene , 1997, The Journal of Biological Chemistry.

[8]  J. J. Sharp,et al.  Small, Membrane-bound, Alternatively Spliced Forms of Ankyrin 1 Associated with the Sarcoplasmic Reticulum of Mammalian Skeletal Muscle , 1997, Journal of Cell Biology.

[9]  B. Forget,et al.  Ankyrin–1 mutations are a major cause of dominant and recessive hereditary spherocytosis , 1996, Nature Genetics.

[10]  M. Kashgarian,et al.  Identification of a small cytoplasmic ankyrin (AnkG119) in the kidney and muscle that binds beta I sigma spectrin and associates with the Golgi apparatus , 1996, The Journal of cell biology.

[11]  S. Orkin,et al.  Isolation and characterization of the cDNA encoding BKLF/TEF-2, a major CACCC-box-binding protein in erythroid cells and selected other cells , 1996, Molecular and cellular biology.

[12]  A. Otsuka,et al.  Ank3 (epithelial ankyrin), a widely distributed new member of the ankyrin gene family and the major ankyrin in kidney, is expressed in alternatively spliced forms, including forms that lack the repeat domain , 1995, The Journal of cell biology.

[13]  S. Orkin,et al.  Functional synergy and physical interactions of the erythroid transcription factor GATA-1 with the Krüppel family proteins Sp1 and EKLF , 1995, Molecular and cellular biology.

[14]  Stuart H. Orkin,et al.  Transcription Factors and Hematopoietic Development (*) , 1995, The Journal of Biological Chemistry.

[15]  V. Bennett,et al.  AnkyrinG. A new ankyrin gene with neural-specific isoforms localized at the axonal initial segment and node of Ranvier. , 1995, The Journal of biological chemistry.

[16]  D. Brenner,et al.  A single promoter directs both housekeeping and erythroid preferential expression of the human ferrochelatase gene. , 1994, The Journal of biological chemistry.

[17]  S. Saad,et al.  Red cell membrane protein abnormalities in hereditary spherocytosis in Brazil , 1994, British journal of haematology.

[18]  S. Orkin,et al.  Regulation of the erythroid Kruppel-like factor (EKLF) gene promoter by the erythroid transcription factor GATA-1. , 1994, The Journal of biological chemistry.

[19]  J. Bieker,et al.  Analyses of beta-thalassemia mutant DNA interactions with erythroid Krüppel-like factor (EKLF), an erythroid cell-specific transcription factor. , 1994, The Journal of biological chemistry.

[20]  O. Shalev,et al.  Combined spectrin and ankyrin deficiency is common in autosomal dominant hereditary spherocytosis. , 1993, Blood.

[21]  A. Haese,et al.  Cooperation of GATA-1 and Sp1 can result in synergistic transcriptional activation or interference. , 1993, The Journal of biological chemistry.

[22]  E. Hall,et al.  Complex patterns of sequence variation and multiple 5' and 3' ends are found among transcripts of the erythroid ankyrin gene. , 1993, The Journal of biological chemistry.

[23]  J. Bieker,et al.  A novel, erythroid cell-specific murine transcription factor that binds to the CACCC element and is related to the Krüppel family of nuclear proteins , 1993, Molecular and cellular biology.

[24]  L. Peters,et al.  Ankyrins: structure and function in normal cells and hereditary spherocytes. , 1993, Seminars in hematology.

[25]  L. Kunkel,et al.  The structural and functional diversity of dystrophin , 1993, Nature Genetics.

[26]  P. Romeo,et al.  CCACC-binding or simian-virus-40-protein-1-binding proteins cooperate with human GATA-1 to direct erythroid-specific transcription and to mediate 5' hypersensitive site 2 sensitivity of a TATA-less promoter. , 1993, European journal of biochemistry.

[27]  R. Myers,et al.  Discrimination among potential activators of the beta-globin CACCC element by correlation of binding and transcriptional properties , 1993, Molecular and cellular biology.

[28]  D. Martin,et al.  Functional erythroid promoters created by interaction of the transcription factor GATA-1 with CACCC and AP-1/NFE-2 elements. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[29]  V. Bennett,et al.  Ankyrins. Adaptors between diverse plasma membrane proteins and the cytoplasm. , 1992, The Journal of biological chemistry.

[30]  L. Zon,et al.  Activation of the erythropoietin receptor promoter by transcription factor GATA-1. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. Mallet,et al.  Oligodeoxyribonucleotide ligation to single-stranded cDNAs: a new tool for cloning 5' ends of mRNAs and for constructing cDNA libraries by in vitro amplification. , 1991, Nucleic acids research.

[32]  E. Otto,et al.  Isolation and characterization of cDNAs encoding human brain ankyrins reveal a family of alternatively spliced genes , 1991, The Journal of cell biology.

[33]  N. Andrews,et al.  A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. , 1991, Nucleic acids research.

[34]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[35]  Adrian Bird,et al.  Alternative chromatin structure at CpG islands , 1990, Cell.

[36]  Y. Kan,et al.  cDNA sequence for human erythrocyte ankyrin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Samuel E. Lux,et al.  Analysis of cDNA for human erythrocyte ankyrin indicates a repeated structure with homology to tissue-differentiation and cell-cycle control proteins , 1990, Nature.

[38]  R. Schimke,et al.  Chimeric 3-hydroxy-3-methylglutaryl coenzyme A reductase-dihydrofolate reductase genes display bidirectional expression and unidirectional regulation in stably transfected cells , 1989, Molecular and cellular biology.

[39]  F. Grosveld,et al.  Two tissue-specific factors bind the erythroid promoter of the human porphobilinogen deaminase gene. , 1989, Nucleic acids research.

[40]  M. Frohman,et al.  Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[41]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[42]  T. Osborne,et al.  HMG CoA reductase: A negatively regulated gene with unusual promoter and 5′ untranslated regions , 1984, Cell.

[43]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[44]  D. Seshasayee,et al.  Functional interaction of GATA1 with erythroid Krüppel-like factor and Sp1 at defined erythroid promoters. , 1996, Blood.

[45]  S. Orkin,et al.  Hematopoiesis: how does it happen? , 1995, Current opinion in cell biology.

[46]  S. J. Higgins,et al.  Gene transcription: a practical approach. , 1993 .

[47]  S. Sassa,et al.  The molecular defect of ferrochelatase in a patient with erythropoietic protoporphyria. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[48]  A. Bird,et al.  Use of restriction enzymes to detect potential gene sequences in mammalian DNA , 1987, Nature.

[49]  Robert Tjian,et al.  Promoter-specific activation of RNA polymerase II transcription by Sp1 , 1986 .